Coronavirus disease 2019 (COVID-19) infection primarily involves the respiratory system but
has many noteworthy extra pulmonary manifestations as well. We write this review to …

The multifaceted interaction between coronavirus disease 2019 (COVID-19) and the
endocrine system has been a major area of scientific research over the past two years …

Objective COVID-19 affects multiple endocrine organ systems during the disease course.
However, follow-up data post-COVID-19 is scarce; hitherto available limited data suggest …

A variety of inflammatory conditions may directly involve the endocrine glands, leading to
endocrine dysfunction that can cause severe consequences on patients' health, if left …

Pituitary apoplexy (PA) is a rare clinical syndrome due to pituitary hemorrhage or infarction.
It is characterized by the sudden onset of one or more of the following: severe headache …

Purpose This review aims to collect and examine recent research findings regarding
hypopituitarism and COVID-19, focusing on the virus's impact on the pituitary gland and the …

Pituitary apoplexy (PA) may complicate the course of coronavirus disease 2019 (COVID-19),
posing a potential threat to life. Among vaccines designed to prevent COVID-19, there are …

Pituitary apoplexy (PA) is a clinical syndrome caused by acute hemorrhage and/or infarction
of the pituitary gland, most commonly in the setting of a pituitary macroadenoma. PA …

SARS-CoV-2 infection, responsible for the coronavirus disease 2019 (COVID-19), can
impair any organ system including endocrine glands. However, hypothalamic–pituitary …

Purpose Pregnancy is a known risk factor for Pituitary Apoplexy (PA) but there is a lack of
consistency in the literature regarding non-gestational risk factors responsible for PA …